Stopping or Decreasing Opioid Therapy in Patients on Chronic Opioid Therapy by Joseph V. Pergolizzi (4997790)

Decreasing the Peril of Antimicrobial Resistance Through Enhanced Health Literacy in Outpatient Settings: An Underrecognized Approach to Advance Antimicrobial Stewardship by Elizabeth D. Hermsen (8085392)

A comparison between different rTMS protocols. by Marcus Persson (20496333)

Subjects:

The Scania aTBS implementation study (SATIS) trial profile. by Marcus Persson (20496333)

Subjects:

Demographic information and treatment history for all participants (N = 20) in the Scania aTBS implementation study (SATIS) at inclusion. by Marcus Persson (20496333)

Subjects:

The design and the timeline of the study. by Rabab Ahmed Rasheed (12536918)

“…An immunohistochemical study showed an increase in the inflammatory TNF-α and the proliferative PCNA markers. Treatment with DIA markedly decreased the prostate weight and plasma hormones, improved tissue redox balance, repaired the histological changes, and increased the proapoptotic caspase 3 expression besides the substantial reduction in TNF-α and PCNA expression. …”

Depression score before and after treatment and at 30-day follow-up, in the PP-group (n = 15) that finished the treatment program and did not receive ECT-treatment between finishin... by Marcus Persson (20496333)

Subjects:

Study design and patient distribution. by Seon-Mi Kim (2984172)

Decreased Injection Site Pain Associated With Phosphate-Free Etanercept Formulation in Rheumatoid Arthritis or Psoriatic Arthritis Patients: A Randomized, Controlled Trial by Stanley Cohen (411535)

Study design. by Marina Shestakova (4530472)

Excel data file with all collected data. by Marcus Persson (20496333)

Subjects:

Correlation scatter plot showing the relation between change in depression score from before to after treatment to self-rated expectations at baseline. by Marcus Persson (20496333)

Subjects:

Cinacalcet administered early in the inactive phase markedly decrease parathyroid Ki-67 index. by Søren Egstrand (10906087)

Marking example. by Qingjun Yu (1649473)

The proportion of lake area which exhibited decreases (blue bars) versus increases (green bars) in chl-a for the largest 18 lakes in the world. by Benjamin M. Kraemer (7526225)

Study design and settings. by Hyun Jin Han (18592254)

Generalizable improvement of QOL measures on day 7 vs. infusion day. by Jordan K. Abbott (8934239)

Subjects:

Baseline characteristics of the patients. by Richard S. Legro (8086748)

Study design. by Sarah Frederike Brose (16052578)

Subjects:

Deletion of <i>sagA</i> alone results in a decrease in nasopharyngeal infection. by Blake A. Shannon (14197601)